Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 19, 2018
Pharmacy Choice - News - Front Page Healthcare News - February 19, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/19/18 - "Cell Culture Medium and Methods for Enhancing Recombinant Antibody Purity" in Patent Application Approval Process (USPTO 20180030495)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors CHENG, Xiwen; YAN, Chengwei; YANG, Bin; SUEN, Wen-Chen; WENG, Yuancan; DENG, Chongfei, filed on January 13, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents.
2/19/18 - "Compositions and Methods for Transplantation of Colon Microbiota" in Patent Application Approval Process (USPTO 20180028573)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SADOWSKY, Michael J.; KHORUTS, Alexander; WEINGARDEN, Alexa R.; HAMILTON, Matthew J., filed on June 19, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. Thi
2/19/18 - "Devices for Detection of Antibodies against Therapeutic Drugs" in Patent Application Approval Process (USPTO 20180031569)
"Surprisingly, in the case of many therapeutic drugs which have already been approved for marketing by regulatory authorities and are considered safe by healthcare professionals and patients, often ADA responses to them may result in adverse reactions of varying negative consequences, for example life-threatening IgE- or IgG-mediated anaphylaxis or
2/19/18 - "Etanercept Formulations Stabilized with Xylitol" in Patent Application Approval Process (USPTO 20180028668)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Manning, Mark; Murphy, Brian, filed on September 26, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Coherus Bioscie
2/19/18 - "Method and System for Dose Rate Regulation in Drug Infusion Treatment" in Patent Application Approval Process (USPTO 20180028750)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors DAHLIN, Hans; HOJDMO, Jorgen, filed on January 26, 2016, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compa
2/19/18 - "Methods of Detecting Cancer" in Patent Application Approval Process (USPTO 20180030145)
By a News Reporter-Staff News Editor at Cancer Vaccine Week A patent application by the inventors Soler, David C.; Sloan, Andrew E.; Cooper, Kevin D.; McCormick, Thomas S.; Young, Andrew B., filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondent
2/19/18 - "Panobinostat Dosages for Multiple Myeloma" in Patent Application Approval Process (USPTO 20180028497)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Lin, Rong; Capdeville, Renaud; Grazioli, Laura; Mu, Song; Paul, Sofia; Binlich, Florence, filed on February 17, 2016, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx corresponde
2/19/18 - "Pathology Determination Assistance Device, Method and Storage Medium" in Patent Application Approval Process (USPTO 20180032673)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors KINOSHITA, Moritoshi; HIGASHIYAMA, Ryo; KOGA, Daisuke, filed on September 3, 2014, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is ass
2/19/18 - "Pharmaceutical Compositions" in Patent Application Approval Process (USPTO 20180028548)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SHAREEF, Mohammad Ajmal; SAHU, Mrutunjaya; HANDA, Ajaykumar, filed on January 12, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application i
2/19/18 - "Pharmaceutical Formulation of Racecadotril" in Patent Application Approval Process (USPTO 20180028448)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Poli, Piero; Fiorino, Alessandro; Piazzolla, Tommaso Roberto, filed on December 23, 2015, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application
2/19/18 - "Pharmaceutical Preparation Comprising Recombinant HcG" in Patent Application Approval Process (USPTO 20180030107)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Cottingham, Ian; Plaksin, Daniel; White, Richard Boyd, filed on May 3, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been
2/19/18 - "Preparation Method for Praziquantel and Intermediate Compounds Thereof" in Patent Application Approval Process (USPTO 20180030049)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ZHANG, Fuli; YANG, Zhezhou; BAO, Rusheng; XU, Weiwei; BAI, Hua, filed on February 12, 2015, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent applicati
2/19/18 - "System and Method for Monitoring Pharmaceutical Usage" in Patent Application Approval Process (USPTO 20180032699)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Carrender, Curtis L.; Morrisey, Daniel; Sainion, Soneer, filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not
2/19/18 - 60 Pharmaceuticals 60P Receives Priority Review Designation For Malaria Drug
By a News Reporter-Staff News Editor at Pharma Business Week 60 Degrees Pharmaceuticals received Priority Review Designation from the United States Food and Drug Administration for Tafenoquine for prevention of malaria in adults. The FDA informed 60 P of this designation upon filing of its' New Drug Application. TQ has the advantage of a convenie
2/19/18 - Abide Therapeutics to Participate in February 2018 Investor Conferences
By a News Reporter-Staff News Editor at Clinical Trials Week Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced that Alan Ezekowitz, CEO and President, will present an overview of the company at the 20th Annual BIO CEO& Investor Confer
2/19/18 - Ambulatory Care Center performs 900 surgeries since December [Peninsula, The (Qatar)]
Dr Khalid Mohammed Al Jalham, with other officials during a media briefing yesterday. Doha: The Ambulatory Care Center of Hamad Medical Corporation, a first of its kind facility in the country, offers patients a range of elective surgical procedures that require fewer hours of hospitalisation as well as limited inpatient care services. The Centre o
2/19/18 - An enhanced recovery program reduced total hospital costs and improved patient outcomes
By a News Reporter-Staff News Editor at Gastroenterology Week CHICAGO: A standardized protocol for managing patients immediately before, during, and after colorectal operations not only improved clinical outcomes, it also significantly reduced overall hospital costs. Already in use throughout Europe for several years, the enhanced recovery approa
2/19/18 - AstraZeneca's IMFINZI approved for Stage III nsclc
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
2/19/18 - AstraZeneca: Imfinzi Receives FDA Approval To Treat Unresectable Stage III NSCLC
LONDON- AstraZeneca PLC and MedImmune announced the. US FDA has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. The approval is based on the positive PFS data from the Phase III PACIFIC trial
2/19/18 - BerGenBio completes recruitment into first stage of Phase II breast cancer trial with selective AXL inhibitor bemcentinib combined with KEYTRUDA
Bergen, Norway, 19 February 2018- BerGenBio ASA announces that it has completed enrolment, ahead of schedule, of the planned 28 patients into the first stage of its Phase II clinical trial evaluating its investigational oral selective AXL inhibitor bemcentinib in combination with the Merck& Co., Inc., Kenilworth, N.J., USA anti-PD-1 therapy KEYTRUD
2/19/18 - BerGenBio Completes Recruitment Into First Stage of Phase II Breast Cancer Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA
BerGenBio ASA announces that it has completed enrolment, ahead of schedule, of the planned 28 patients into the first stage of its Phase II clinical trial evaluating its investigational oral selective AXL inhibitor bemcentinib in combination with the Merck& Co., Inc., Kenilworth, N.J., USA anti-PD-1 therapy KEYTRUDA as a potential new treatmen
2/19/18 - Black patients more likely to be excluded from prostate cancer trials
By a News Reporter-Staff News Editor at Clinical Trials Week Boston, MA Clinical trials can offer patients access to cutting-edge treatments with the potential to extend their survival and shape the standard of care in the future. A team of investigators from Brigham and Women's Hospital studied a potential barrier that may be disproportionatel
2/19/18 - Bonti Announces Dosing of the First Patient in the SHINE-1 Phase 2 Clinical Study Evaluating EB-001 for Scar Reduction
By a News Reporter-Staff News Editor at Pharma Business Week Bonti, a privately-held, clinical-stage biotechnology company, announced the initiation of the SHINE clinical program, aimed at scar reduction using its novel neurotoxin. Considering the potential advantages of this profile, Bonti continues developing products to pursue targeted aesthet
2/19/18 - Breathing problems linked to drug that treats opioid addiction
By a News Reporter-Staff News Editor at Pharma Business Week A drug used to treat opioid addiction could cause breathing problems in some obese patients, according to a new study from UT scientists. It is one of three drugs approved by the US Food and Drug Administration to help patients undergoing treatment for opioid abuse. The discovery of the
2/19/18 - Cell Culture Market Analysis Focusing On Major Companies (ABB Ltd., General Electric Company, Eaton, Siemens AG), Research Methodology, and Forecast By 2024
Cell Culture Market By Product, Application, Process, End-User, Geography- Industry Trends, Trends, Size, Share and Forecast to 2024. The Global Cell Culture Market accounted to USD 12,585.9 million in 2016 growing at a CAGR of 10.0% during the forecast period of 2017 to 2024. *Higher Prices of Cell Biology Research.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415